Biologics4Life Secures License to Bone Tissue Regeneration Technology

Biologics4Life completed an exclusive licensing agreement to secure rights to initial technologies for advanced bone tissue regeneration. This agreement strengthens the company’s intellectual property portfolio and is a step toward the development of its scaffold materials.

“Accomplishment of this key milestone was made possible...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us